Jayamas Medica Industri TBK PT
IDX:OMED
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
173
222
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
Jayamas Medica Industri TBK PT
|
Revenue
|
1.8T
IDR
|
|
Cost of Revenue
|
-1.2T
IDR
|
|
Gross Profit
|
599.3B
IDR
|
|
Operating Expenses
|
-284.5B
IDR
|
|
Operating Income
|
314.8B
IDR
|
|
Other Expenses
|
-26.9B
IDR
|
|
Net Income
|
287.9B
IDR
|
Income Statement
Jayamas Medica Industri TBK PT
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue |
1 739 054
N/A
|
2 135 951
+23%
|
2 550 396
+19%
|
3 005 525
+18%
|
1 736 990
-42%
|
1 767 482
+2%
|
1 805 296
+2%
|
1 835 015
+2%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(1 186 562)
|
(1 455 607)
|
(1 733 948)
|
(2 053 382)
|
(1 184 990)
|
(1 204 632)
|
(1 225 205)
|
(1 235 704)
|
|
| Gross Profit |
552 492
N/A
|
680 345
+23%
|
816 448
+20%
|
952 143
+17%
|
552 000
-42%
|
562 849
+2%
|
580 091
+3%
|
599 310
+3%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(180 587)
|
(239 043)
|
(307 049)
|
(367 274)
|
(252 340)
|
(253 791)
|
(259 819)
|
(284 511)
|
|
| Selling, General & Administrative |
(161 261)
|
(213 566)
|
(275 948)
|
(343 625)
|
(221 875)
|
(242 755)
|
(250 956)
|
(247 190)
|
|
| Depreciation & Amortization |
(22 939)
|
(28 983)
|
(35 527)
|
(36 190)
|
(25 810)
|
(15 380)
|
(9 898)
|
(10 333)
|
|
| Other Operating Expenses |
3 613
|
3 506
|
4 426
|
12 542
|
(4 656)
|
4 344
|
1 035
|
(26 988)
|
|
| Operating Income |
371 905
N/A
|
441 301
+19%
|
509 399
+15%
|
584 869
+15%
|
299 660
-49%
|
309 059
+3%
|
320 272
+4%
|
314 800
-2%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
270
|
(1 106)
|
629
|
11 472
|
25 593
|
31 718
|
49 757
|
52 151
|
|
| Non-Reccuring Items |
0
|
0
|
2
|
293
|
1 251
|
0
|
1 113
|
1 103
|
|
| Total Other Income |
(67)
|
(81)
|
(94)
|
(314)
|
(341)
|
(430)
|
(532)
|
(435)
|
|
| Pre-Tax Income |
372 109
N/A
|
440 114
+18%
|
509 936
+16%
|
596 320
+17%
|
326 162
-45%
|
340 347
+4%
|
370 611
+9%
|
367 618
-1%
|
|
| Net Income | |||||||||
| Tax Provision |
(81 602)
|
(92 627)
|
(107 779)
|
(122 326)
|
(65 180)
|
(72 263)
|
(76 040)
|
(77 525)
|
|
| Income from Continuing Operations |
290 507
|
347 487
|
402 157
|
473 994
|
260 982
|
268 084
|
294 571
|
290 093
|
|
| Income to Minority Interest |
(4 725)
|
(5 282)
|
(5 763)
|
(5 829)
|
(1 622)
|
(1 687)
|
(1 874)
|
(2 190)
|
|
| Net Income (Common) |
285 782
N/A
|
342 205
+20%
|
396 394
+16%
|
468 166
+18%
|
259 360
-45%
|
266 397
+3%
|
292 696
+10%
|
287 902
-2%
|
|
| EPS (Diluted) |
10.56
N/A
|
14.87
+41%
|
17.23
+16%
|
20.35
+18%
|
9.59
-53%
|
9.84
+3%
|
10.81
+10%
|
10.64
-2%
|
|
You don't have any saved screeners yet
